Health Economics

Why collect economic outcomes in clinical trials?

Collecting economic outcomes such as resource use and health-related quality of life alongside clinical endpoints provides the evidence payers and HTA bodies need to judge value for money.

Reasons in single-arm studies

• Resource use and cost estimation for the new intervention.
• Inputs to health economic models.
• Matched cohort designs through linkage with registries.

Support we offer

• Economic sub-study protocol.
• Incorporating economic outcomes in the eCRF.
• Analysis and report or manuscript.

Modelling

We develop and adapt cost-effectiveness and budget impact models tailored to local decision makers.